QT
CRNX icon

Quantbot Technologies’s Crinetics Pharmaceuticals CRNX Stock Holding History

Quantbot Technologies’s Portfolio CRNX Stock Details CRNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-127
Closed -$6.49K – 1545
2024
Q4 		$6.49K Sell
127
-155
-55% -$8.67K ﹤0.01% 1388
2024
Q3 		$14.4K Buy
+282
New +$14.5K ﹤0.01% 1350
2022
Q4 		– Sell
-99
Closed -$1K – 1742
2022
Q3 		$1K Buy
+99
New +$2.02K ﹤0.01% 1529
2022
Q1 		– Sell
-5,126
Closed -$145K – 1702
2021
Q4 		$145K Buy
5,126
+1,726
+51% +$42.6K 0.01% 796
2021
Q3 		$71K Buy
3,400
+2,700
+386% +$56.5K 0.01% 1044
2021
Q2 		$13K Buy
+700
New +$12.3K ﹤0.01% 1275

Other funds holding CRNX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Quantbot Technologies's CRNX Position: Q1 2025 in Review

Quantbot Technologies sold out of Crinetics Pharmaceuticals (CRNX) in Q1 2025, closing a stake of 127 shares — an estimated $6.49K sold.

Quantbot Technologies first reported a position in CRNX in Q2 2021 and held it in 6 quarters. The position peaked at $145K in Q4 2021. 227 funds tracked by Wall St. Rank hold CRNX as of Q1 2025.

  • Quantbot Technologies reported no remaining Crinetics Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Quantbot Technologies sold 127 Crinetics Pharmaceuticals shares in Q1 2025, an estimated $6.49K.
  • Quantbot Technologies first reported a position in Crinetics Pharmaceuticals in Q2 2021 and held it in 6 quarters.
  • Quantbot Technologies's Crinetics Pharmaceuticals position peaked at $145K in Q4 2021.
  • 227 funds tracked by Wall St. Rank held Crinetics Pharmaceuticals as of Q1 2025.

Based on Quantbot Technologies's 13F filing for Q1 2025, filed 13 May 2025.